Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human α-synuclein A53T transgenic mice during early adulthood

© 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry..

Point mutations in the α-synuclein coding gene may lead to the development of Parkinson's disease (PD). PD is often accompanied by other psychiatric conditions, such as anxiety, depression, and drug use disorders, which typically emerge in adulthood. Some of these point mutations, such as SNCA and A30T, have been linked to behavioral effects that are not commonly associated with PD, especially regarding alcohol consumption patterns. In this study, we investigated whether the familial PD point mutation A53T is associated with changes in alcohol consumption behavior and emotional states at ages not yet characterized by α-synuclein accumulation. The affective and alcohol-drinking phenotypes remained unaltered in female PDGF-hA53T-synuclein-transgenic (A53T) mice during both early and late adulthood. Brain region-specific activation of ceramide-producing enzymes, acid sphingomyelinase (ASM), and neutral sphingomyelinase (NSM), known for their neuroprotective properties, was observed during early adulthood but not in late adulthood. In males, the A53T mutation was linked to a reduction in alcohol consumption in both early and late adulthood. However, male A53T mice displayed increased anxiety- and depression-like behaviors during both early and late adulthood. Enhanced ASM activity in the dorsal mesencephalon and ventral hippocampus may potentially contribute to these adverse behavioral effects of the mutation in males during late adulthood. In summary, the A53T gene mutation was associated with diverse changes in emotional states and alcohol consumption behavior long before the onset of PD, and these effects varied by sex. These alterations in behavior may be linked to changes in brain ceramide metabolism.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:168

Enthalten in:

Journal of neurochemistry - 168(2024), 3 vom: 20. März, Seite 269-287

Sprache:

Englisch

Beteiligte Personen:

Kalinichenko, Liubov S [VerfasserIn]
Kohl, Zacharias [VerfasserIn]
Mühle, Christiane [VerfasserIn]
Hassan, Zurina [VerfasserIn]
Hahn, Agnes [VerfasserIn]
Schmitt, Eva-Maria [VerfasserIn]
Macht, Kilian [VerfasserIn]
Stoyanov, Lyubomir [VerfasserIn]
Moghaddami, Schayan [VerfasserIn]
Bilbao, Roberto [VerfasserIn]
Eulenburg, Volker [VerfasserIn]
Winkler, Jürgen [VerfasserIn]
Kornhuber, Johannes [VerfasserIn]
Müller, Christian P [VerfasserIn]

Links:

Volltext

Themen:

A53T
Alcohol
Alpha-Synuclein
Ceramide
Ceramides
Depression
EC 3.1.4.12
Journal Article
Neutral sphingomyelinase
Parkinson's disorder
Research Support, Non-U.S. Gov't
Sphingomyelin Phosphodiesterase

Anmerkungen:

Date Completed 23.02.2024

Date Revised 21.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/jnc.16051

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367748436